Other Fundraising Rounds

Collate Raises $95M Other

Collate raises $95 million in new funding led by Redpoint Ventures to expand its AI platform for automating life sciences regulatory documentation.

by Ben Murray

Updated June 04, 2026

Collate Raises $95M Other at $1B Valuation

Collate, based in San Francisco, is a software startup that develops AI tools designed to automate complex documentation and regulatory paperwork for the life sciences industry. The company recently announced it has raised $95 million in a new funding round, bringing its total capital raised to $125 million.

Investors

The funding round was led by Redpoint Ventures. The company has previously secured investment from top-tier firms including First Round and Conviction Partners.

Collate Use of Funds

Collate plans to utilize the new capital to scale its operations and meet the surging demand from pharmaceutical companies, medical device manufacturers, and biotech firms seeking to outsource their regulatory documentation processes to AI-driven systems.

About Collate

Founded in 2024 by Surbhi Sarna and Nate Smith, Collate leverages Large Language Models to parse complex clinical data and regulatory filings. The company mission is to provide an accurate, patient-safe automation solution that reduces the time required for life sciences documentation by up to 90 percent.